Back Bay Life Science Advisors provides life science strategy and investment banking guidance and execution to global biopharma and medtech companies across every stage and sector.
With offices in Boston, Toronto and Frankfurt, Back Bay guides companies of all sizes on technology and drug development, from planning and initial concept to product commercialization, franchising and licensing, partnering, M&A, divestiture and partnering.
Back Bay teams are comprised of MDs, PhDs, scientific and banking experts with a love for building the next generation of life science breakthroughs. We guide innovators in oncology, cell and gene therapy, cardiology, neuroinflammation, rare disease and more.
View highlights from our portfolio of projects and life science transactions and subscribe to The Life Science Report, our life science industry podcast, at https://www.bblsa.com/podcasts. www.bblsa.com